Cite
HARVARD Citation
Pan, J. et al. (2021). Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Leukemia & lymphoma. 62 (3), pp. 590-597. [Online].